Minnesota's 2026 Cannabis Omnibus Bill: A Consumer's Guide to New Edibles, Hemp Products, and Medical Access
Minnesota lawmakers approved SF 4401, the most comprehensive cannabis policy update since adult-use legalization, when both chambers passed the 105-page omnibus bill on May 17, 2026. The legislation now sits on Governor Tim Walz's desk awaiting his signature, which is widely expected in the coming days.
The bill touches nearly every corner of the state's cannabis industry, from how large cultivators grow flower to how patients access medical products. But for everyday consumers, the changes that matter most are straightforward: you will soon be able to buy stronger edibles, encounter a brand-new class of hemp-cannabis products at your local dispensary, and, if you hold a medical cannabis registry card, receive qualifying products delivered directly to your door.
Here is a detailed breakdown of what SF 4401 means for Minnesota cannabis shoppers and patients.
Edibles Limits Double Under the New Law
The most widely discussed consumer change in SF 4401 is the increase to edible product limits. Under current law, adult-use cannabis edibles are capped at 5 milligrams of THC per serving and 50 milligrams per package. Once the bill takes effect, those limits jump to 10 milligrams per serving and 200 milligrams per package for qualifying products, according to Marijuana.School's analysis of the omnibus.
What does that mean at the checkout counter? A single package can now contain up to twenty 10-milligram servings. Before the change, reaching 200 milligrams required purchasing four separate packages. For experienced consumers, this is a meaningful quality-of-life shift. For new users, it makes reading labels even more important, since a single package now holds a substantial total dose.
Edibles sold under the new "ratio hemp-infused cannabis product" category must display individual servings separated by scoring or wrapping, so consumers can see exactly how much they are taking with each piece.
Beverage rules also shift. Standard cannabis beverages remain capped at 10 milligrams per serving, with a two-serving maximum per container. Hemp retailers, starting August 1, 2026, will be permitted to sell large-format beverages in child-resistant, resealable bottles of at least 750 milliliters containing 17 or more servings at 5 milligrams of THC each, per the Minnesota House Session Daily coverage.
A New Product Category Arrives: Ratio Hemp-Infused Cannabis Products
Perhaps the most novel element of SF 4401 for dispensary shelves is a brand-new product class: the "ratio hemp-infused cannabis product."
These products combine cannabis extract with hemp-derived cannabinoids such as CBD, CBG, CBN, or CBC. The allowable limits are significantly higher than standard edibles: up to 10 milligrams of THC per serving alongside up to 100 milligrams of nonintoxicating hemp-derived cannabinoids per serving, per Nothing But Canna's full bill breakdown.
The practical effect is that consumers who prefer the balanced, full-spectrum effect from combining THC with CBD or CBG will have more options made and sold by licensed Minnesota businesses. Previously, products with these cannabinoid ratios were largely sourced through unregulated or out-of-state channels. The new category brings them under OCM oversight, with mandatory labeling, batch testing, and allergen disclosure.
Packages of these products must carry a statement noting: "This product contains nonintoxicating cannabinoids derived from hemp." The labeling requirement ensures consumers know exactly what they are buying.
For dispensaries around the Twin Cities and greater Minnesota, this new category is likely to expand shelf variety considerably. If you are shopping at a Minneapolis or Saint Paul dispensary and see an unfamiliar label referencing "ratio hemp-infused," you are looking at this new product class.
Hemp Edibles Now Available Alongside Adult-Use Products
SF 4401 also authorizes licensed cannabis retailers to stock lower-potency hemp edibles alongside their adult-use inventory, provided those hemp products come from licensed hemp businesses that meet OCM labeling standards, according to Nothing But Canna.
This matters for consumers who prefer lower-dose options. Lower-potency hemp edibles remain subject to stricter caps of 5 milligrams per serving and 50 milligrams per package, but their availability at licensed dispensaries gives shoppers a regulated, tested option for mild effects without needing to visit a separate hemp retailer.
The bill also gives the Office of Cannabis Management sole regulatory authority over all hemp edibles, repealing the previous pharmacy board statute that governed the category. That consolidation should reduce regulatory confusion for both businesses and consumers shopping in the Minnesota cannabis products market.
Medical Cannabis Patients Gain Home Delivery Access
One of the most significant changes for Minnesota's medical cannabis community is the creation of a new medical cannabis delivery endorsement. Under SF 4401, licensed dispensaries may obtain this endorsement to provide direct delivery to qualifying patients at their homes, according to the Nothing But Canna analysis.
Minnesota's medical cannabis program serves tens of thousands of registered patients who rely on cannabis for qualifying conditions including cancer, PTSD, chronic pain, and multiple sclerosis. For patients with mobility limitations or those in rural parts of the state far from a licensed dispensary, home delivery could be a meaningful expansion of access.
Previously, patients were required to visit a dispensary in person to obtain their products. The delivery endorsement changes that, though individual dispensaries will need to opt into the endorsement and establish delivery logistics. Expect rollout to vary by market and region.
The Medical and Adult-Use Supply Chains Are Merging
For medical cannabis patients, the omnibus bill makes another structural change with direct implications for product quality and availability. The bill eliminates the requirement that medical and recreational marijuana products be kept entirely separate throughout the supply chain.
Under the old rules, cultivators and manufacturers had to maintain distinct inventory for medical and adult-use channels from seed to dispensary shelf. The new framework removes that separation at every point except the final sale. At the register, medical products will be identified with a sticker and sold without state excise taxes, as outlined in MJ Biz Daily's coverage.
The practical benefit for patients is access to a wider selection of products, since cultivators are no longer required to grow separate batches for medical use. Patients will also potentially see better supply consistency as the two channels draw from the same inventory pool.
Hemp Businesses Get a Bridge to the Licensed Cannabis Market
SF 4401 also addresses a looming challenge for Minnesota's hemp industry: a federal policy expected to restrict hemp products containing more than 0.4 milligrams of THC by late 2026. Under current state law, businesses holding hemp licenses cannot simultaneously hold cannabis business licenses.
The new omnibus creates a legislative bridge, allowing hemp license holders to transition into the licensed cannabis market rather than close or pivot to non-THC products, per MJ Biz Daily. Businesses that have been selling hemp-derived THC products through convenience stores, smoke shops, and hemp-specific retailers now have a pathway to become fully licensed cannabis operators under OCM oversight.
For consumers, this may mean that some familiar brand names from the hemp retail world will begin appearing on licensed dispensary shelves as those businesses complete the transition.
The Macrobusiness License Launches January 1, 2027
SF 4401 creates a new tier in the cannabis business structure: the macrobusiness license. This tier is intended for larger cultivators and manufacturers and allows for a larger canopy footprint than existing license categories. The bill sets a ceiling of 38,000 square feet of plant canopy for indoor macrobusiness cultivators, according to the Minnesota House.
The macrobusiness license replaces the medical combination business license and launches January 1, 2027. The immediate consumer-facing effect may take time to materialize, but over the following growing seasons, the larger cultivation footprint should help address the supply shortage that has kept wholesale prices high and contributed to inconsistent product availability at Minnesota dispensaries.
Minnesota's cannabis market recorded approximately $22 million in sales in March 2026 alone, but supply constraints have kept prices elevated compared to more mature markets. Expanding production capacity through the macrobusiness tier is the legislature's attempt to bring supply closer to demand.
What to Expect at Your Dispensary in the Coming Months
SF 4401 passed both chambers on May 17, 2026, and is awaiting Governor Walz's signature as of late May. Most provisions take effect upon signing. The macrobusiness license launches January 1, 2027, and certain hemp beverage rules take effect August 1, 2026.
Here is a practical timeline for Minnesota shoppers:
Upon signing: The ratio hemp-infused cannabis product category becomes lawful. Dispensaries can begin sourcing and stocking these products once supply is available. Medical delivery endorsements become available for dispensaries to apply for.
August 1, 2026: Hemp retailers may begin selling large-format beverages (750mL or larger) with up to 17 servings at 5mg THC each.
January 1, 2027: Macrobusiness licenses go live. Supply is expected to expand as larger operators come online in the months that follow.
If you are visiting a dispensary soon, it is worth asking your budtender when they expect to carry ratio hemp-infused products and whether delivery will be available for medical cardholders. Early adopters may find limited selection in the first weeks, but the category is expected to grow quickly.
For a full list of licensed dispensaries near you, and details on Minnesota's cannabis laws and regulations, the MN Cannabis Hub maintains up-to-date guides for shoppers across the state. You can also browse our cannabis strains guide and products overview to plan your next dispensary visit.
Frequently Asked Questions
What is the new edibles limit under Minnesota's 2026 omnibus bill?
Under SF 4401, adult-use cannabis edibles sold as "ratio hemp-infused cannabis products" can contain up to 10 milligrams of THC per serving and up to 200 milligrams of THC per package, a significant increase from the previous limit of 5 milligrams per serving and 50 milligrams per package.
What is a ratio hemp-infused cannabis product?
A ratio hemp-infused cannabis product is a new product category created by SF 4401 that combines cannabis extract with hemp-derived nonintoxicating cannabinoids such as CBD, CBG, CBN, or CBC. These products allow up to 100 milligrams of nonintoxicating cannabinoids per serving alongside up to 10 milligrams of THC per serving and must be labeled as containing hemp-derived cannabinoids.
Will Minnesota medical cannabis patients be able to get home delivery?
Yes. SF 4401 creates a new medical cannabis delivery endorsement that licensed dispensaries may obtain to offer direct delivery to qualifying patients at their homes. Individual dispensaries will need to apply for and implement the endorsement, so availability will vary by location throughout the state.
When does the 2026 cannabis omnibus bill take effect in Minnesota?
Most provisions of SF 4401 take effect upon Governor Walz's signature, which is expected in late May or early June 2026. Hemp beverage rules take effect August 1, 2026, and the new macrobusiness license tier launches January 1, 2027.
Can hemp businesses in Minnesota now transition to selling licensed cannabis products?
SF 4401 creates a legislative bridge for hemp businesses to enter the licensed cannabis market in anticipation of federal restrictions on hemp-derived THC products expected by late 2026. Businesses must complete the licensing process through the Office of Cannabis Management before selling licensed cannabis products.
How does the medical and adult-use supply chain merger affect patients?
The omnibus bill eliminates the requirement that medical and adult-use cannabis products be kept separate throughout the supply chain, with the only difference remaining at point of sale, where medical products are marked with a sticker and sold without state excise taxes. This should improve product selection and supply consistency for registered medical cannabis patients across Minnesota.